US Patent Issued to Harmony Biosciences Management on March 24 for "Treatment of fragile x syndrome with cannabidiol" (Pennsylvania, North Carolina Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,664, issued on March 24, was assigned to Harmony Biosciences Management Inc. (Plymouth Meeting, Pa.).

"Treatment of fragile x syndrome with cannabidiol" was invented by Joseph Palumbo (Saint Davids, Pa.), Stephen V. O'Quinn (Wake Forest, N.C.), Terri Sebree (Gladwyne, Pa.), Marcel Bonn-Miller (Lexington, N.C.) and Donna Gutterman (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology relates to a method of treating one or more behavioral symptoms of autism spectrum disorder (ASD) in a subject by administering an effective amount of cannabidiol (CBD). Specifically, subjects having moderate to severe ASD and relatively h...